Merck KGaA, Darmstadt, Germany logo

Merck KGaA, Darmstadt, Germany

Europe, Hessen, Germany, Darmstadt

Description

We are Merck KGaA, Darmstadt, Germany and its global affiliates. We are a vibrant science and technology company.

Investor Profile

Merck KGaA, Darmstadt, Germany has made 5 investments, with 3 in the past 12 months and 0% as lead.

Stage Focus

  • Series B (40%)
  • Series A (40%)
  • Series Unknown (20%)

Country Focus

  • United States (60%)
  • Switzerland (20%)
  • Spain (20%)

Industry Focus

  • Biotechnology
  • Artificial Intelligence (Ai)
  • Health Care
  • Life Science
  • Oncology
  • Product Research
  • Machine Learning
  • Consumer Electronics
  • Medical Device
  • Nanotechnology
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Merck KGaA, Darmstadt, Germany frequently co-invest with?

Nextech Invest
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Casdin Capital
North America, New York, United States, New York
Co-Investments: 1
Co-Investments: 1
Tallwood Venture Capital
North America, California, United States, Menlo Park
Co-Investments: 1
Biotechnology Value Fund
North America, California, United States, San Francisco
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 1
CC
North America, New York, United States, New York
Co-Investments: 1
Blackstone Group
North America, New York, United States, New York
Co-Investments: 1
M Ventures
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 2

Which angels does Merck KGaA, Darmstadt, Germany often collaborate with?

NL
North America, Massachusetts, United States, Cambridge
Shared Deals: 1

What are some of recent deals done by Merck KGaA, Darmstadt, Germany?

INBRAIN Neuroelectronics

Barcelona, Catalonia, Spain

INBRAIN Neuroelectronics is a BCI therapeutics company using graphene to build the least invasive and most intelligent neural platform

Artificial Intelligence (AI)BiotechnologyConsumer ElectronicsHealth CareMedical DeviceNanotechnologySemiconductorTherapeutics
Series BOct 29, 2024
Amount Raised: $49,771,699
Idrx

Plymouth, Massachusetts, United States

Idrx is a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment.

BiotechnologyLife ScienceOncologyProduct Research
Series BAug 7, 2024
Amount Raised: $120,000,000
Thintronics

San Francisco, California, United States

Thintronics is a Consumer Electronics company.

Series AAug 5, 2024
Nucleai

Chicago, Illinois, United States

Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes.

Artificial Intelligence (AI)Health CareMachine Learning
Series UnknownApr 3, 2024
Amount Raised: $14,000,000
MoonLake Immunotherapeutics

Zug, Zug, Switzerland

MoonLake Immunotherapeutics is a clinical-stage biopharmaceuticals company.

Biotechnology
Series AMay 11, 2021